FI900175A0 - Menetelmä valmistaa farmaseuttisesti arvokkaita fuusioituja bentsatsepiineja - Google Patents

Menetelmä valmistaa farmaseuttisesti arvokkaita fuusioituja bentsatsepiineja

Info

Publication number
FI900175A0
FI900175A0 FI900175A FI900175A FI900175A0 FI 900175 A0 FI900175 A0 FI 900175A0 FI 900175 A FI900175 A FI 900175A FI 900175 A FI900175 A FI 900175A FI 900175 A0 FI900175 A0 FI 900175A0
Authority
FI
Finland
Prior art keywords
method prepares
pharmaceutically valuable
benzazepines
fused benzazepines
prepares pharmaceutically
Prior art date
Application number
FI900175A
Other languages
English (en)
Swedish (sv)
Other versions
FI93212B (fi
FI93212C (fi
Inventor
Joel Gilbert Berger
Wei Kong Chang
Elijah Herman Us Gold
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of FI900175A0 publication Critical patent/FI900175A0/fi
Publication of FI93212B publication Critical patent/FI93212B/fi
Application granted granted Critical
Publication of FI93212C publication Critical patent/FI93212C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/32—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems containing carbocyclic rings other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Electroluminescent Light Sources (AREA)
FI900175A 1987-07-15 1990-01-12 Menetelmä valmistaa farmaseuttisesti arvokkaita fuusioituja bentsatsepiineja FI93212C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US8701636 1987-07-15
PCT/US1987/001636 WO1989000561A1 (en) 1987-07-15 1987-07-15 Fused benzazepines
EP87110253 1987-07-16
EP87110253A EP0299101B1 (en) 1987-07-15 1987-07-16 Fused benzazepines

Publications (3)

Publication Number Publication Date
FI900175A0 true FI900175A0 (fi) 1990-01-12
FI93212B FI93212B (fi) 1994-11-30
FI93212C FI93212C (fi) 1995-03-10

Family

ID=26108265

Family Applications (1)

Application Number Title Priority Date Filing Date
FI900175A FI93212C (fi) 1987-07-15 1990-01-12 Menetelmä valmistaa farmaseuttisesti arvokkaita fuusioituja bentsatsepiineja

Country Status (13)

Country Link
EP (2) EP0363353B1 (fi)
JP (1) JPH0678317B2 (fi)
AT (1) ATE78467T1 (fi)
AU (1) AU617651B2 (fi)
DE (1) DE3780649T2 (fi)
DK (1) DK162889C (fi)
ES (1) ES2043623T3 (fi)
FI (1) FI93212C (fi)
GR (1) GR3006671T3 (fi)
HU (1) HU203537B (fi)
NO (1) NO177264C (fi)
WO (1) WO1989000561A1 (fi)
ZA (1) ZA875183B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4973586A (en) 1986-01-16 1990-11-27 Schering Corporation Fused benzazepines, compositions of, and medical use thereof
PL168408B1 (pl) * 1989-08-03 1996-02-29 Smithkline Beecham Biolog Sposób wytwarzania stransformowanego mikroorganizmu PL
US5362728A (en) * 1990-02-02 1994-11-08 Schering Corporation 4,5-bridged-2,3,4,5-tetrahydro-1H-3-benzazepine-7-ols and derivatives and compositions and methods employing such compounds
JPH07137816A (ja) * 1993-11-15 1995-05-30 Tokai Univ 地下空洞内貯蔵装置
CN1688584A (zh) * 2002-08-29 2005-10-26 先灵公司 治疗肥胖和中枢神经系统疾病的选择性d1/d5受体拮抗剂
JP2006526021A (ja) * 2003-05-22 2006-11-16 シェーリング　コーポレイション 肥満およびｃｎｓ障害を治療する選択的ｄ１／ｄ５レセプタアンタゴニストとしての５ｈ−ベンゾ［ｄ］ナフト［２，１−ｂ］アゼピン誘導体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3393192A (en) * 1965-04-26 1968-07-16 Schering Corp Novel benzazepines
CH481110A (de) * 1967-02-17 1969-11-15 Geigy Ag J R Verfahren zur Herstellung von 1,2,4,5-Tetrahydro-3-azepinen
US4680298A (en) * 1983-05-31 1987-07-14 Schering Corporation Tricyclic anti-allergy and use as anti-inflammatory agents
KR900007781B1 (ko) * 1986-01-16 1990-10-20 쉐링 코포레이션 융합된 벤즈아제핀

Also Published As

Publication number Publication date
DK162889C (da) 1992-05-11
AU8037887A (en) 1989-02-13
WO1989000561A1 (en) 1989-01-26
ATE78467T1 (de) 1992-08-15
DK162889B (da) 1991-12-23
NO900186D0 (no) 1990-01-12
EP0299101B1 (en) 1992-09-23
DK9390D0 (da) 1990-01-12
FI93212B (fi) 1994-11-30
NO900186L (no) 1990-01-12
EP0299101A1 (en) 1989-01-18
ES2043623T3 (es) 1994-01-01
EP0363353A1 (en) 1990-04-18
EP0363353B1 (en) 1992-07-22
NO177264B (no) 1995-05-08
NO177264C (no) 1995-08-16
HU203537B (en) 1991-08-28
AU617651B2 (en) 1991-12-05
DE3780649T2 (de) 1992-12-10
DE3780649D1 (de) 1992-08-27
JPH0678317B2 (ja) 1994-10-05
GR3006671T3 (fi) 1993-06-30
JPH02504629A (ja) 1990-12-27
DK9390A (da) 1990-03-12
ZA875183B (en) 1988-04-08
FI93212C (fi) 1995-03-10

Similar Documents

Publication Publication Date Title
CA2000786A1 (en) 3-piperidinyl-1,2-benzisoxazoles
FI20000353A (fi) 3,4,4-trisubstituoidun piperidinyyli-N-alkyylikarboksylaatin valmistus ja välituotteet
FR2707882B1 (fr) Nouveaux kits thérapeutiques anti-médiateurs protéiques, procédé de préparation et compositions pharmaceutiques les renfermant.
DE3887625D1 (de) Verfahren zur Herstellung von 1,1,1-Trifluorodichlorethan und von 1,1,1,2-Tetrafluorchlorethan.
WO1987004430A3 (en) Fused benzazepines
ATE293595T1 (de) Thyroidhormon-analoga und verfahren zu ihrer herstellung
TW362096B (en) Novel piperidine derivatives and the process for preparing the same
PT80752B (pt) Processo de preparacao de composicoes farmaceuticas solidas contendo di-hidropiridinas
BR8806217A (pt) Derivados de 2,2-difluorciclopropiletano,processo para sua preparacao,composicoes praguicidas e aplicacao
DE69427955D1 (de) Verfahren zur Herstellung von 2,2-Difluorketensilylacetalen und alpha,alpha-Difluor-beta -Silyloxy-1,3-Dioxolan-4-Propansäureestern
DE59604829D1 (de) Kontinuierliches Verfahren zur Herstellung von 4-Amino-2,2,6,6-tetramethylpiperidin
FI900175A0 (fi) Menetelmä valmistaa farmaseuttisesti arvokkaita fuusioituja bentsatsepiineja
DE69413410T2 (de) Abschmelzelektrodeverfahren zur herstellung von mikrolegierten produkten
FR2714063B1 (fr) Procédé de préparation de collagène à partir de cnidaires, et compositions obtenues utilisables en cosmétique.
DE3783199D1 (de) Verfahren zur herstellung von 4,4' diaminodiphenylmethan und derivaten davon.
FI891473A (fi) Menetelmä terapeuttisesti käyttökelpoisten 4-aryyli-4-piperidiinikarbinolien valmistamiseksi
DE68912809D1 (de) Verfahren zur Herstellung von Bis(2,2,6,6-tetramethyl-4-piperidyl)amin.
NO984681D0 (no) Forbedret fremgangsmÕte for fremstilling av enantiomerisk ren azetidin-2-karboksylsyre
KR960701075A (ko) 신규 2'-메틸리덴 뉴클레오티드 화합물, 그의 제조 방법 및 그의 약학적 용도[novel 2'-methylidenenucleotide compound, process for producing the same, and pharmaceutical use thereof]
DE3585388D1 (de) Verfahren zur herstellung von 1,3 cyclohexandionderivaten und zwischenprodukte dazu.
DE59812284D1 (de) Verfahren zur Herstellung von 4-Amino-2,2,6,6-tetramethyl-piperidin
DE3768926D1 (de) Verfahren und rohling zur herstellung von werkzeugen.
DE3863665D1 (de) 2-(benzhydrylsulfonyl) acetamid, verfahren zu dessen herstellung und dessen verwendung in der therapie.
DE3880072D1 (de) N-phenyl-2,2,6,6-tetrahalogencyclohexanimin und verfahren zur herstellung von derivaten des 2,2,6,6-tetrahalogencyclohexanimins und von derivaten des 2,6-dihalogenanilins.
PL277260A1 (en) Method of obtaining novel derivatives of tetrahydropyridine

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: SCHERING CORPORATION